TotalMarketCap

Trevi Therapeutics

TRVINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.842 B

$12.93 -7.58%

Close of 6 Nov 2026

As of 6 Nov 2026, Trevi Therapeutics (TRVI) has a market capitalization of $1.84B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$42.8M

Loss-making

Shares outstanding

142,475,841

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #98Harmony BiosciencesHRMY$1.91B
  2. #99Sarepta TherapeuticsSRPT$1.85B
  3. #100Trevi TherapeuticsTRVI$1.84B
  4. #101Maravai LifesciencesMRVI$1.81B
  5. #102Stoke TherapeuticsSTOK$1.70B

What if Trevi Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$198,187.10

Per share 15,334× higher

Bitcoin $1.53T

$10,723.56

Per share 830× higher

Apple $5.02T

$35,204.44

Per share 2,724× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Trevi Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.